Why is Pharmaids Pharma falling/rising?
As of 06-Nov, Pharmaids Pharmaceuticals Ltd's stock price is Rs 46.64, down 3.26%, and has underperformed significantly against the Sensex, with a year-to-date decline of 33.83%. The stock is trading below all major moving averages, indicating a bearish trend amid high volatility and investor uncertainty.
As of 06-Nov, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 46.64, which represents a decrease of Rs 1.57 or 3.26%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 6.38% during this period. Today's trading saw the stock reach an intraday high of Rs 51.91 but ultimately closed at its low. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a rise in delivery volume by 6.9% against the 5-day average, the overall performance today was still below the sector average by 2.49%.In the broader market context, Pharmaids Pharmaceuticals has significantly underperformed compared to the benchmark Sensex over various time frames. For instance, in the past week, the stock has declined by 6.92%, while the Sensex has only fallen by 1.30%. Over the past month, Pharmaids has seen a steep decline of 16.80%, contrasting sharply with the Sensex's gain of 1.86%. This stark difference highlights the stock's struggles in the current market environment, where it has also recorded a year-to-date decline of 33.83% compared to the Sensex's increase of 6.62%. The combination of high volatility and a wide trading range today further reflects investor uncertainty surrounding the stock's future performance.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
